1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Artificial Intelligence Drug R&D Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 AI Platfrom
1.2.3 Analytics Service
1.3 Market by Application
1.3.1 Global Artificial Intelligence Drug R&D Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Drug Discovery
1.3.3 Precision Medicine
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Artificial Intelligence Drug R&D Market Perspective (2017-2028)
2.2 Artificial Intelligence Drug R&D Growth Trends by Region
2.2.1 Artificial Intelligence Drug R&D Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Artificial Intelligence Drug R&D Historic Market Size by Region (2017-2022)
2.2.3 Artificial Intelligence Drug R&D Forecasted Market Size by Region (2023-2028)
2.3 Artificial Intelligence Drug R&D Market Dynamics
2.3.1 Artificial Intelligence Drug R&D Industry Trends
2.3.2 Artificial Intelligence Drug R&D Market Drivers
2.3.3 Artificial Intelligence Drug R&D Market Challenges
2.3.4 Artificial Intelligence Drug R&D Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Artificial Intelligence Drug R&D Players by Revenue
3.1.1 Global Top Artificial Intelligence Drug R&D Players by Revenue (2017-2022)
3.1.2 Global Artificial Intelligence Drug R&D Revenue Market Share by Players (2017-2022)
3.2 Global Artificial Intelligence Drug R&D Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Artificial Intelligence Drug R&D Revenue
3.4 Global Artificial Intelligence Drug R&D Market Concentration Ratio
3.4.1 Global Artificial Intelligence Drug R&D Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Artificial Intelligence Drug R&D Revenue in 2021
3.5 Artificial Intelligence Drug R&D Key Players Head office and Area Served
3.6 Key Players Artificial Intelligence Drug R&D Product Solution and Service
3.7 Date of Enter into Artificial Intelligence Drug R&D Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Artificial Intelligence Drug R&D Breakdown Data by Type
4.1 Global Artificial Intelligence Drug R&D Historic Market Size by Type (2017-2022)
4.2 Global Artificial Intelligence Drug R&D Forecasted Market Size by Type (2023-2028)
5 Artificial Intelligence Drug R&D Breakdown Data by Application
5.1 Global Artificial Intelligence Drug R&D Historic Market Size by Application (2017-2022)
5.2 Global Artificial Intelligence Drug R&D Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Artificial Intelligence Drug R&D Market Size (2017-2028)
6.2 North America Artificial Intelligence Drug R&D Market Size by Type
6.2.1 North America Artificial Intelligence Drug R&D Market Size by Type (2017-2022)
6.2.2 North America Artificial Intelligence Drug R&D Market Size by Type (2023-2028)
6.2.3 North America Artificial Intelligence Drug R&D Market Share by Type (2017-2028)
6.3 North America Artificial Intelligence Drug R&D Market Size by Application
6.3.1 North America Artificial Intelligence Drug R&D Market Size by Application (2017-2022)
6.3.2 North America Artificial Intelligence Drug R&D Market Size by Application (2023-2028)
6.3.3 North America Artificial Intelligence Drug R&D Market Share by Application (2017-2028)
6.4 North America Artificial Intelligence Drug R&D Market Size by Country
6.4.1 North America Artificial Intelligence Drug R&D Market Size by Country (2017-2022)
6.4.2 North America Artificial Intelligence Drug R&D Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Artificial Intelligence Drug R&D Market Size (2017-2028)
7.2 Europe Artificial Intelligence Drug R&D Market Size by Type
7.2.1 Europe Artificial Intelligence Drug R&D Market Size by Type (2017-2022)
7.2.2 Europe Artificial Intelligence Drug R&D Market Size by Type (2023-2028)
7.2.3 Europe Artificial Intelligence Drug R&D Market Share by Type (2017-2028)
7.3 Europe Artificial Intelligence Drug R&D Market Size by Application
7.3.1 Europe Artificial Intelligence Drug R&D Market Size by Application (2017-2022)
7.3.2 Europe Artificial Intelligence Drug R&D Market Size by Application (2023-2028)
7.3.3 Europe Artificial Intelligence Drug R&D Market Share by Application (2017-2028)
7.4 Europe Artificial Intelligence Drug R&D Market Size by Country
7.4.1 Europe Artificial Intelligence Drug R&D Market Size by Country (2017-2022)
7.4.2 Europe Artificial Intelligence Drug R&D Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Artificial Intelligence Drug R&D Market Size (2017-2028)
8.2 Asia-Pacific Artificial Intelligence Drug R&D Market Size by Type
8.2.1 Asia-Pacific Artificial Intelligence Drug R&D Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Artificial Intelligence Drug R&D Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Artificial Intelligence Drug R&D Market Share by Type (2017-2028)
8.3 Asia-Pacific Artificial Intelligence Drug R&D Market Size by Application
8.3.1 Asia-Pacific Artificial Intelligence Drug R&D Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Artificial Intelligence Drug R&D Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Artificial Intelligence Drug R&D Market Share by Application (2017-2028)
8.4 Asia-Pacific Artificial Intelligence Drug R&D Market Size by Region
8.4.1 Asia-Pacific Artificial Intelligence Drug R&D Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Artificial Intelligence Drug R&D Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Artificial Intelligence Drug R&D Market Size (2017-2028)
9.2 Latin America Artificial Intelligence Drug R&D Market Size by Type
9.2.1 Latin America Artificial Intelligence Drug R&D Market Size by Type (2017-2022)
9.2.2 Latin America Artificial Intelligence Drug R&D Market Size by Type (2023-2028)
9.2.3 Latin America Artificial Intelligence Drug R&D Market Share by Type (2017-2028)
9.3 Latin America Artificial Intelligence Drug R&D Market Size by Application
9.3.1 Latin America Artificial Intelligence Drug R&D Market Size by Application (2017-2022)
9.3.2 Latin America Artificial Intelligence Drug R&D Market Size by Application (2023-2028)
9.3.3 Latin America Artificial Intelligence Drug R&D Market Share by Application (2017-2028)
9.4 Latin America Artificial Intelligence Drug R&D Market Size by Country
9.4.1 Latin America Artificial Intelligence Drug R&D Market Size by Country (2017-2022)
9.4.2 Latin America Artificial Intelligence Drug R&D Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Artificial Intelligence Drug R&D Market Size (2017-2028)
10.2 Middle East & Africa Artificial Intelligence Drug R&D Market Size by Type
10.2.1 Middle East & Africa Artificial Intelligence Drug R&D Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Artificial Intelligence Drug R&D Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Artificial Intelligence Drug R&D Market Share by Type (2017-2028)
10.3 Middle East & Africa Artificial Intelligence Drug R&D Market Size by Application
10.3.1 Middle East & Africa Artificial Intelligence Drug R&D Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Artificial Intelligence Drug R&D Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Artificial Intelligence Drug R&D Market Share by Application (2017-2028)
10.4 Middle East & Africa Artificial Intelligence Drug R&D Market Size by Country
10.4.1 Middle East & Africa Artificial Intelligence Drug R&D Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Artificial Intelligence Drug R&D Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 IBM Watson
11.1.1 IBM Watson Company Details
11.1.2 IBM Watson Business Overview
11.1.3 IBM Watson Artificial Intelligence Drug R&D Introduction
11.1.4 IBM Watson Revenue in Artificial Intelligence Drug R&D Business (2017-2022)
11.1.5 IBM Watson Recent Developments
11.2 BioXel
11.2.1 BioXel Company Details
11.2.2 BioXel Business Overview
11.2.3 BioXel Artificial Intelligence Drug R&D Introduction
11.2.4 BioXel Revenue in Artificial Intelligence Drug R&D Business (2017-2022)
11.2.5 BioXel Recent Developments
11.3 Insilico Medicine
11.3.1 Insilico Medicine Company Details
11.3.2 Insilico Medicine Business Overview
11.3.3 Insilico Medicine Artificial Intelligence Drug R&D Introduction
11.3.4 Insilico Medicine Revenue in Artificial Intelligence Drug R&D Business (2017-2022)
11.3.5 Insilico Medicine Recent Developments
11.4 Gatehouse Bio
11.4.1 Gatehouse Bio Company Details
11.4.2 Gatehouse Bio Business Overview
11.4.3 Gatehouse Bio Artificial Intelligence Drug R&D Introduction
11.4.4 Gatehouse Bio Revenue in Artificial Intelligence Drug R&D Business (2017-2022)
11.4.5 Gatehouse Bio Recent Developments
11.5 Google DeepMind
11.5.1 Google DeepMind Company Details
11.5.2 Google DeepMind Business Overview
11.5.3 Google DeepMind Artificial Intelligence Drug R&D Introduction
11.5.4 Google DeepMind Revenue in Artificial Intelligence Drug R&D Business (2017-2022)
11.5.5 Google DeepMind Recent Developments
11.6 Genpact Cora
11.6.1 Genpact Cora Company Details
11.6.2 Genpact Cora Business Overview
11.6.3 Genpact Cora Artificial Intelligence Drug R&D Introduction
11.6.4 Genpact Cora Revenue in Artificial Intelligence Drug R&D Business (2017-2022)
11.6.5 Genpact Cora Recent Developments
11.7 Cyclica Inc
11.7.1 Cyclica Inc Company Details
11.7.2 Cyclica Inc Business Overview
11.7.3 Cyclica Inc Artificial Intelligence Drug R&D Introduction
11.7.4 Cyclica Inc Revenue in Artificial Intelligence Drug R&D Business (2017-2022)
11.7.5 Cyclica Inc Recent Developments
11.8 QuantumBlack
11.8.1 QuantumBlack Company Details
11.8.2 QuantumBlack Business Overview
11.8.3 QuantumBlack Artificial Intelligence Drug R&D Introduction
11.8.4 QuantumBlack Revenue in Artificial Intelligence Drug R&D Business (2017-2022)
11.8.5 QuantumBlack Recent Developments
11.9 Nq Medical
11.9.1 Nq Medical Company Details
11.9.2 Nq Medical Business Overview
11.9.3 Nq Medical Artificial Intelligence Drug R&D Introduction
11.9.4 Nq Medical Revenue in Artificial Intelligence Drug R&D Business (2017-2022)
11.9.5 Nq Medical Recent Developments
11.10 Phenomic AI
11.10.1 Phenomic AI Company Details
11.10.2 Phenomic AI Business Overview
11.10.3 Phenomic AI Artificial Intelligence Drug R&D Introduction
11.10.4 Phenomic AI Revenue in Artificial Intelligence Drug R&D Business (2017-2022)
11.10.5 Phenomic AI Recent Developments
11.11 Palantir Technologies
11.11.1 Palantir Technologies Company Details
11.11.2 Palantir Technologies Business Overview
11.11.3 Palantir Technologies Artificial Intelligence Drug R&D Introduction
11.11.4 Palantir Technologies Revenue in Artificial Intelligence Drug R&D Business (2017-2022)
11.11.5 Palantir Technologies Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
